<DOC>
	<DOCNO>NCT00745277</DOCNO>
	<brief_summary>1 . Briefly describe purpose protocol : - The purpose study see low dose vs. high dose study drug , carbidopa , effect movement subject Parkinson 's disease . The low dose study drug 75 mg high dose 450mg . 2 . Briefly describe procedure subject undergo : - Subjects take part 2 screen visit one week apart determine eligibility . Subjects randomly choose start either high low dose carbidopa take 4 week . Subjects call 2 , 4 , 6 7 day visit ask start dose study drug . The investigator leave subject message investigator reach . If problem , investigator schedule come clinic within next 2 day . - Subjects outpatient visit 2 week screen hospital admission 2 week . At hospital , subject stay 3 day . They blood drawn Parkinson 's disease assess finger tap exercise , time walking , look uncontrolled movement . - The subject receive opposite dose carbidopa 4 week . Subjects call 2 , 4 , 6 7 day visit ask start dose study drug . The investigator leave message reach . If problem , investigator schedule come clinic within next 2 day . - The outpatient visit hospital admission repeat . At end second hospital admission , treatment study subject go back original Parkinson 's disease medication . The study end follow phone call clinic visit 2 - 4 week final hospital admission . 3 . If applicable , briefly describe survey/interview instrument use . - Subjects fill daily diary asks movement throughout day 3 day come Oregon Clinical Translational Research Institute . 4 . Briefly describe data analyze address purpose protocol . - Finger tap rate compare high low dose study drug use see one group slow rate .</brief_summary>
	<brief_title>High Low Dose Treatment Carbidopa Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<criteria>Idiopathic Parkinson 's disease patient judge history physical examination . Increase finger tap rate affect side ( back forth two counter , explain Materials Methods section ) Willing hold PD med night 3 day . Symptoms PD least 3 year , carbidopa/levodopa therapy least 1 year . Subjects must take minimum 600mg levodopa day Severe limitation downgaze , balance problem , history early fall , sign suggestive atypical parkinsonian syndrome . Substantial history cardiac cerebrovascular disease investigator ' judgment would lead risk adverse outcome . Pregnancy breastfeed , highly likely become pregnant inpatient admission . Positive BHCG time screen visit . Age &lt; 35 &gt; 85 . Hypotensive ( i.e . sustain sit sbp &lt; 95 ) bradycardic ( sustain hr &lt; 54 ) initial visit , history . Very frequent treatment refractory nausea and/or vomit . Sustained significant hypokalemia hypomagnesemia . Refractory hypertension , determine investigator . Heavy alcohol use , determine clinical history current alcoholism . Renal failure severe renal insufficiency determine investigator . Substantial hepatic impairment , history determine investigator . Hemoglobin &lt; 11 g/dl . Absolute neutrophils count &lt; 1000 per µl . Platelets &lt; 120,000 per µl . Psychosis use antipsychotic medication . Current illicit drug abuse . Mini mental status examination ( MMSE ) score &lt; 24 would Any medical psychiatric condition could pose risk individual compromise ability participate study . Deep brain stimulator place</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>carbidopa</keyword>
	<keyword>levodopa</keyword>
	<keyword>Parkinson 's disease</keyword>
</DOC>